VHL and neoplasm: The inactivation of the von Hippel-Lindau (VHL) tumor suppressor gene leads to increased activity of the hypoxia-induced factor (HIF) in the tumor cell and eventually to the overexpression of platelet-derived growth factor and VEGF [78,79].